MAPT and Alzheimer disease: Promising therapeutic targets for AD may include protein kinases and phosphatases modulating tau phosphorylation, tau acetylation inhibitors, tau glycosylation modulators, microtubule stabilizers, tau truncation modulators, and tau aggregation inhibitors [82,84,85].